Summary

U.S. Veterinary Eye Care Market Summary

The U.S. veterinary eye care market size was estimated at USD 1.66 billion in 2024 and is projected to reach USD 2.71 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. The market is advancing owing to factors such as expanding veterinary eye care avenues, increasing advocacy for rationale use of antibiotics, growing involvement of veterinary professionals in spreading awareness, and technological advancements in veterinary eye care.

The veterinary eye care sector in the U.S. is experiencing significant growth, driven by advancements in surgical techniques, genetic research, and diagnostic technologies. These developments are expanding the scope of eye care for animals, offering new hope for conditions that were once considered untreatable.

A notable example is the use of retinal reattachment surgery, or retinopexy, conducted in January 2025, by UC Davis, to address retinal tears in dogs. This procedure involves replacing the natural gel in the eye with silicone oil to reposition the retina, effectively restoring vision in affected animals. Such specialized surgeries are becoming more accessible, thanks to improvements in surgical equipment and training.

Genetic research is also playing a pivotal role in veterinary eye care. Studies such as the March 2025 article published by dvm360 have identified specific genetic mutations responsible for conditions such as progressive retinal atrophy (PRA) in dogs. For instance, a 3-base pair deletion in the GTPBP2 gene has been linked to PRA, providing a basis for genetic testing and informed breeding decisions. This approach aims to prevent the hereditary transmission of such conditions, thereby reducing their prevalence in future generations.

In terms of treatment options, the use of latanoprost in managing glaucoma in cats highlights the complexities of veterinary ophthalmology. While latanoprost has shown efficacy in lowering intraocular pressure in cats, its limitations underscore the need for ongoing research and development of more effective therapies tailored to feline physiology.

Furthermore, the adoption of laser technology for treating canine eyelid tumors represents a significant advancement in non-invasive surgical techniques. As per March 2025 article published by dvm360, laser treatments offer precision and reduced recovery times compared to traditional methods, enhancing the overall treatment experience for both pets and their owners.

Collectively, these innovations are contributing to a dynamic and rapidly evolving veterinary ophthalmology landscape. As the field continues to progress, it holds the promise of improved outcomes for animals suffering from a range of ocular conditions, reflecting a broader trend toward specialized and compassionate veterinary care.

U.S. Veterinary Eye Care Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. veterinary eye care market report based on animal, product, indication, and distribution channel:

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Canine
• Feline
• Equine
• Bovine
• Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Devices & Instruments
o Diagnostic Devices
o Tonometers
o Ophthalmic Test Kits
o Electroretinogram (ERG)
o Fundus Camera
o Ophthalmoscopes
o Pachymeter
o Other Diagnostic Devices
o Treatment Devices
o Lenses
o Bandage Lenses
o Intraocular Lenses
o Laser Devices
o Other Treatment Devices
• Medications
o Antibiotics
o NSAIDs
o Corticosteroids
o Lubricants / Artificial Tears
o Analgesics / Pain Relievers
o Other Medications
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Eyelid Abnormalities
• Cataract
• Glaucoma
• Retinal Complications
• Uveitis
• Conjunctivitis
• Corneal Complications
• Other Indications
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• Specialty Stores
• E-Commerce
• Other Distribution Channels

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Country Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Veterinary Eye Care Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding Veterinary Eye Care Avenues
3.2.1.2. Increasing Advocacy for Rationale Use of Antibiotics
3.2.1.3. Growing Involvement of Veterinary Professionals in Spreading Awareness
3.2.1.4. Technological Advancements in Veterinary Eye Care
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost Of Veterinary Ophthalmic Procedures
3.2.2.2. Limitations of Medications in Ophthalmology Care
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.2.5. Industry Analysis
3.2.5.1. Porter’s Five Forces Analysis
3.2.5.2. PESTLE by SWOT Analysis
3.2.6. Pricing Analysis
3.2.7. Estimated Animal Population by key species, 2021 - 2024
Chapter 4. U.S. Veterinary Eye Care Market: Animal Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Veterinary Eye Care Market: Animal Movement Analysis
4.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
4.4. Canine
4.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Feline
4.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Equine
4.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Bovine
4.7.1. Bovine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Other Animals
4.8.1. Other Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Veterinary Eye Care Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Veterinary Eye Care Market: Product Movement Analysis
5.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Devices & Instruments
5.4.1. Devices & Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.1. Diagnostic Devices
5.4.1.1.1. Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.2. Tonometers
5.4.1.2.1. Tonometers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.3. Ophthalmic Test Kits
5.4.1.3.1. Ophthalmic Test Kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.4. Electroretinogram (ERG)
5.4.1.4.1. Electroretinogram (ERG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.5. Fundus Camera
5.4.1.5.1. Fundus Camera Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.6. Ophthalmoscopes
5.4.1.6.1. Ophthalmoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.7. Pachymeter
5.4.1.7.1. Pachymeter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.8. Other Diagnostic Devices
5.4.1.8.1. Other Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Treatment Devices
5.5.1. Treatment Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.1. Lenses
5.5.1.1.1. Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.1.2. Bandage Lenses
5.5.1.1.2.1. Bandage Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.1.3. Intraocular Lenses
5.5.1.1.3.1. Intraocular Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.2. Laser Devices
5.5.1.2.1. Laser Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.3. Other Treatment Devices
5.5.1.3.1. Other Treatment Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Medications
5.6.1. Medications Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.2. Antibiotics
5.6.2.1. Antibiotics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.3. NSAIDs
5.6.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.4. Corticosteroids
5.6.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.5. Lubricants / Artificial Tears
5.6.5.1. Lubricants / Artificial Tears Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.6. Analgesics / Pain Relievers
5.6.6.1. Analgesics / Pain Relievers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6.7. Other Medications
5.6.7.1. Other Medications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Veterinary Eye Care Market: By Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Veterinary Eye Care Market: By Indication Movement Analysis
6.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
6.3.1. Eyelid Abnormalities
6.3.1.1. Eyelid Abnormalities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. Cataract
6.3.2.1. Cataract Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Glaucoma
6.3.3.1. Glaucoma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3.2. Retinal Complications
6.3.3.3. Retinal Complications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.4. Uveitis
6.3.4.1. Uveitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.5. Conjunctivitis
6.3.5.1. Conjunctivitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.6. Corneal Complications
6.3.6.1. Corneal Complications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.7. Other Indications
6.3.7.1. Other Indications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Veterinary Eye Care Market: By Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Veterinary Eye Care Market: By Distribution Channel Movement Analysis
7.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
7.3.1. Veterinary Hospitals & Clinics
7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. Specialty Stores
7.3.2.1. Specialty Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. E-Commerce
7.3.3.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Other Distribution Channels
7.3.4.1. Other Distribution Channels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Company Profiles
8.3.1. Merck & Co., Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. An-Vision GmbH
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Jorgensen Laboratories
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. LKC Technologies Inc.
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Accutome Inc.
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Dechra
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Bausch & Lomb Incorporated
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Zoetis Services LLC.
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Ceva Sante Animale
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Sandoz
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Boehringer Ingelheim
8.3.11.1. Participant’s Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. I-Med Animal Health
8.3.12.1. Participant’s Overview
8.3.12.2. Financial Performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. Iridex Corporation
8.3.13.1. Participant’s Overview
8.3.13.2. Financial Performance
8.3.13.3. Product Benchmarking
8.3.13.4. Strategic Initiatives
8.3.14. Baxter (Welch Allyn)
8.3.14.1. Participant’s Overview
8.3.14.2. Financial Performance
8.3.14.3. Product Benchmarking
8.3.14.4. Strategic Initiatives
8.3.15. OptoMed
8.3.15.1. Participant’s Overview
8.3.15.2. Financial Performance
8.3.15.3. Product Benchmarking
8.3.15.4. Strategic Initiatives
8.3.16. Reichert, Inc.
8.3.16.1. Participant’s Overview
8.3.16.2. Financial Performance
8.3.16.3. Product Benchmarking
8.3.16.4. Strategic Initiatives
8.3.17. Occuity
8.3.17.1. Participant’s Overview
8.3.17.2. Financial Performance
8.3.17.3. Product Benchmarking
8.3.17.4. Strategic Initiatives
8.3.18. Strategy Mapping
8.3.19. Mergers & Acquisitions
8.3.20. Partnerships & Collaborations
8.3.21. Product launch
8.3.22. Others
8.4. List of other key players